The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

Background & Aims Narrative reviews of paediatric NAFLD quote prevalences in the general population that range from 9% to 37%; however, no systematic review of the prevalence of NAFLD in children/adolescents has been conducted. We aimed to estimate prevalence of non-alcoholic fatty liver disease (NAFLD) in young people and to determine whether this varies by BMI category, gender, age, diagnostic method, geographical region and study sample size. Methods We conducted a systematic review and meta-analysis of all studies reporting a prevalence of NAFLD based on any diagnostic method in participants 1–19 years old, regardless of whether assessing NAFLD prevalence was the main aim of the study. Results The pooled mean prevalence of NAFLD in children from general population studies was 7.6% (95%CI: 5.5% to 10.3%) and 34.2% (95% CI: 27.8% to 41.2%) in studies based on child obesity clinics. In both populations there was marked heterogeneity between studies (I2 = 98%). There was evidence that prevalence was generally higher in males compared with females and increased incrementally with greater BMI. There was evidence for differences between regions in clinical population studies, with estimated prevalence being highest in Asia. There was no evidence that prevalence changed over time. Prevalence estimates in studies of children/adolescents attending obesity clinics and in obese children/adolescents from the general population were substantially lower when elevated alanine aminotransferase (ALT) was used to assess NAFLD compared with biopsies, ultrasound scan (USS) or magnetic resonance imaging (MRI). Conclusions Our review suggests the prevalence of NAFLD in young people is high, particularly in those who are obese and in males.

[1]  Thomas A Trikalinos,et al.  Simulation-Based Comparison of Methods for Meta-Analysis of Proportions and Rates , 2013 .

[2]  Jan J Barendregt,et al.  Meta-analysis of prevalence , 2013, Journal of Epidemiology & Community Health.

[3]  T. Therneau,et al.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States , 2013, Hepatology.

[4]  M. Zheng,et al.  Upper Limits of Normal for Serum Alanine Aminotransferase Levels in Chinese Han Population , 2012, PloS one.

[5]  S. Rhee,et al.  Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[6]  Eliseo Guallar,et al.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.

[7]  L. Beilin,et al.  Gender‐specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease , 2011, Hepatology.

[8]  Richard D Riley,et al.  Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.

[9]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[10]  J. Stoker,et al.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.

[11]  G. Norman,et al.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. , 2010, Gastroenterology.

[12]  H. A-Kader Nonalcoholic fatty liver disease in children living in the obeseogenic society. , 2009 .

[13]  H. A-Kader,et al.  Nonalcoholic fatty liver disease in children living in the obeseogenic society , 2009, World journal of pediatrics : WJP.

[14]  S. Bellentani,et al.  Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). , 2009, Annals of hepatology.

[15]  A. Diehl,et al.  Mechanisms of disease progression in nonalcoholic fatty liver disease. , 2008, Seminars in liver disease.

[16]  A. Feldstein,et al.  Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.

[17]  P. Angulo,et al.  Obesity and nonalcoholic fatty liver disease. , 2007, Nutrition reviews.

[18]  Andrea Laghi,et al.  MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease , 2007, Acta paediatrica.

[19]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[20]  G. Radetti,et al.  Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. , 2006, Acta paediatrica.

[21]  Dominique Thabut,et al.  The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis , 2005, Comparative hepatology.

[22]  N. Scopinaro,et al.  Liver Damage in Severely Obese Patients: a Clinical-Biochemical-Morphologic Study on 1,000 Liver Biopsies , 2004, Obesity surgery.

[23]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[24]  M. Fishbein,et al.  The Spectrum of Fatty Liver in Obese Children and The Relationship of Serum Aminotransferases to Severity of Steatosis , 2003, Journal of pediatric gastroenterology and nutrition.

[25]  A. Zanella,et al.  Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.

[26]  S. Thompson,et al.  How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.

[27]  J. Sterne,et al.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. , 2000, Journal of clinical epidemiology.

[28]  G. Lockitch,et al.  Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. , 1988, Clinical chemistry.

[29]  P. M. Dennis Clinical Enzymology — A Case Oriented Approach, John A. Lott, Paul L. Wolf. Field, Rich and Associates, Inc., New York (1986), 285, (Popper Books, Sydney). ISBN 0-931729-09-2, paperback. $75.00 , 1987 .

[30]  D. M. Goldberg Structural, Functional, and Clinical Aspects of γ-Glutamyltransferase , 1980 .

[31]  D. M. Goldberg Structural, functional, and clinical aspects of gamma-glutamyltransferase. , 1980, CRC critical reviews in clinical laboratory sciences.

[32]  C. M. Leevy FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE , 1962 .